Items Tagged ‘lung cancer’
September 3, 2019
Research News Roundup–August 2019
Each month, we publish Mayo Clinic’s Research News Roundup. This article includes brief summaries and links to news releases from the preceding month that discuss some of our latest medical research. It also connects readers to related resources. Read on for recent findings of Mayo Clinic Research: Genetically manipulating protein level in colon cancer cells can […]
Tags: Alan Fields, artificial intelligence, atrial fibrillation, basic science, cardiology, cardiovascular disease, chemotherapy, Colin West, colorectal cancer, diabetes, Frank Sinicrope, Lotte Dyrbye
July 25, 2018
Advances in lung cancer immunotherapy and management of immune-mediated adverse events
By Advancing the Science contributor 
Over the last few years, immunotherapy using immune checkpoint inhibitors targeting programmed cell death receptor 1 (PD-1) or programmed cell death receptor ligand 1 (PD-L1) has revolutionized the therapeutic approach to advanced-stage non-small cell lung cancer and numerous other malignancies. Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for […]
Tags: clinical trials, immunotherapy, lung cancer, Mayo Clinic Cancer Center, measles virus
June 5, 2018
Research News Roundup-May 2018
The Mayo Clinic Research News Roundup includes brief summaries and links to research news releases from the past month. It also connects readers to related resources. Read on for more information from Mayo Clinic Research. News flash about hot flashes: They can last longer than you think Mayo Clinic study finds women are experiencing hot flashes, night […]
Tags: All of Us, atrial fibrillation, Center for Individualized Medicine, Center for the Science of Health Care Delivery, Eva Galanis, Gianrico Farrugia, HLHS, hypoplastic left heart syndrome, Judy Boughey, lung cancer, Matthew Goetz, Mayo Clinic Cancer Center
December 29, 2016
Drug combo stems tumor growth in lung cancer
Researchers on Mayo Clinic’s campus in Jacksonville, Florida, have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent. The combination therapy worked in a laboratory study to stop lung adenocarcinoma associated with mutation of the KRAS gene. The study […]
Tags: chemotherapy, Forefront, lung cancer
April 25, 2014
Nicotine Dependence Center: Celebrating 25 Years of Leading-edge Addiction Research
By bobnellis 
From modest beginnings and a single research project, the Nicotine Dependence Center at Mayo Clinic celebrates its 25th anniversary of helping patients overcome their addiction to tobacco. That success has been driven, in large part, by a dedicated and innovative research program. In 1988, when counselors greeted the first patient at Mayo Clinic’s new Nicotine […]